Coagulation and hemorheology profile of patient with stroke and COVID-19: A case series during second wave pandemic

Clin Hemorheol Microcirc. 2022 Jul 7. doi: 10.3233/CH-221504. Online ahead of print.ABSTRACTIn 2021 the delta variant was discovered, heralding the start of the second pandemic wave. This case series aims to analyse and compare the coagulation and hemorheology profiles of COVID-19 patients diagnosed with acute stroke during the pandemic's second wave and ascertain the effect on patient outcomes. This case series reports 4 cases with their respective characteristics. Case 1 reports on COVID-19 patients without comorbidities, Case 2 with comorbidities, Case 3 with strokes in young patients, and Case 4 with strokes in elderly patients. All cases had abnormal coagulation and hemorheology factors with mixed outcomes. Coagulation and hemorheology factors tend to be higher in COVID-19 patients with acute stroke. The value of coagulation and hemorheology factors can be a prognostic outcome in COVID-19 patients with severe disease, especially in patients associated with acute stroke.PMID:35811513 | DOI:10.3233/CH-221504
Source: Clinical Hemorheology and Microcirculation - Category: Hematology Authors: Source Type: research